Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $1.69 | Prev. Close $1.54 | Circuit Range N/A |
Day Range $1.69 - $1.70 | Year Range $1.37 - $11.42 | Volume 882 |
Average Traded $1.70 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $1.69 | $1.70 | +0.00% |
29-Jun-26 | $1.69 | $1.70 | +10.06% |
26-Jun-26 | $1.54 | $1.54 | +4.41% |
24-Jun-26 | $1.48 | $1.48 | +0.34% |
23-Jun-26 | $1.50 | $1.47 | -3.29% |
22-Jun-26 | $1.55 | $1.52 | -1.94% |
18-Jun-26 | $1.58 | $1.55 | -2.21% |